P. Gokcen and K. Ozdil, “A risk factor in the development of hepatocellular carcinoma: Insulin analogues”, Ann Med Res , vol. 29, no. 11, pp. 1209–1213, Nov. 2022, Accessed: Aug. 25, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4328